Anpario (LON:ANP – Get Free Report) had its price target hoisted by Canaccord Genuity Group from GBX 340 ($4.49) to GBX 370 ($4.89) in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 18.40% from the stock’s previous close.
Separately, Shore Capital restated a “house stock” rating on shares of Anpario in a research note on Wednesday, September 11th.
Check Out Our Latest Stock Analysis on ANP
Anpario Price Performance
About Anpario
Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
- Five stocks we like better than Anpario
- Trading Halts Explained
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- 3 Healthcare Dividend Stocks to Buy
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- CD Calculator: Certificate of Deposit Calculator
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.